Hos reumafaktor (RF) positive patienter, blev markante fald i reumafaktor koncentrationerne observeret efter behandling med rituximab i alle tre forsøg (mellem 45- 64%).
In rheumatoid factor (RF) positive patients, marked decreases were observed in rheumatoid factor concentrations following treatment with rituximab in all three studies (range 45-64%).